Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects.
The study is published in Blood Cancer Journal by co-senior authors Drs. David Conrad and John Bell of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa).
While Dr. Bell and his colleagues have been investigating replicating viruses for the treatment of solid cancers for many years, with very promising results, this is the first major success they have had treating blood cancer (leukemia). It is also the first success they have had using a non-replicating virus-derived particle as opposed to a replicating virus.
“Our research indicated that a replicating virus might not be the safest or most effective approach for treating leukemia, so we decided to investigate whether we could make virus-derived particles that no longer replicate but still kill cancer,” said Dr. Conrad, a hematologist conducting research in the Blood and Marrow Transplant Program at The Ottawa Hospital, and currently completing his PhD at OHRI and uOttawa in the Department of Cellular and Molecular Medicine. “We were delighted to see that this novel therapy was very safe at high doses, and worked extremely well in our laboratory leukemia models. We hope to test this in patients in the near future.”
The researchers used a specific method and dose of UV light to transform regular replicating viruses into unique particles that could no longer replicate and spread, but could still enter cancer cells efficiently, kill them and stimulate a strong immune response against the cancer. These particles were able to kill multiple forms of leukemia in the laboratory, including samples taken from local patients who had failed all other therapies. Normal blood cells were not affected. This novel treatment was also successful in mouse models of leukemia. In fact, 80 per cent of the mice that received the therapy had markedly prolonged survival and 60 per cent were eventually cured, while all of the untreated mice died of their leukemia within 20 days.
“Leukemia is a devastating disease that can be very difficult to treat, and new therapies are urgently needed,” said Dr. Conrad. “While we’re still at the early stages of this research, I think this therapy holds a lot of promise because it appears to have a potent, long-lasting effect on leukemia without the debilitating side effects of many cancer therapies used in the clinic right now.
The Latest Bing News on:
Virus-derived particles
- How bird flu spreads to cattle and impacts the industryon April 26, 2024 at 10:00 am
Dairy farms facing an outbreak will have economic losses from caring for sick animals and the temporary reduction in milk sales.
- Bird flu virus in milk poses challenges for dairy industryon April 26, 2024 at 8:47 am
The discovery of fragments of avian flu virus in milk sold in U.S. stores, including in about 20% of samples in initial testing, suggests that the H5N1 virus may be more widespread in dairy cattle ...
- How bird flu virus fragments get into milk sold in stores, and what the spread of H5N1 in cows means for the dairy industry and milk drinkerson April 26, 2024 at 7:18 am
The discovery of viral fragments of avian flu virus in milk sold in U.S. stores suggests that the H5N1 virus may be more widespread in U.S. dairy cattle than previously realized.
- Brain-Eating Amoeba Meets Its Match: Unusual Giant Virus Discovered in Austriaon April 26, 2024 at 5:25 am
A new, unusual giant virus has been discovered at a wastewater treatment plant near Vienna. The single-celled organism Naegleria fowleri ranks among the deadliest human parasites. Matthias Horn and Pa ...
- University of Dundee spin-out bags £4m to develop active biologic drugson April 25, 2024 at 6:31 am
UK-based biotech Glen Clova Scientific has raised £4 million in seed financing to develop a pipeline of a new generation of active biologic drugs.
- Cows' milk particles used for effective oral delivery of drugson April 24, 2024 at 11:16 am
Researchers have found that tiny particles present in cows' milk could offer, for the first time, an effective method for the oral delivery of RNA drugs.
- Giant virus discovered in wastewater treatment plant infects deadly parasiteon April 24, 2024 at 8:37 am
The single-celled organism Naegleria fowleri ranks among the deadliest human parasites. Researchers around Matthias Horn and Patrick Arthofer from the Center for Microbiology and Environmental Systems ...
- GeoVax Labs gets grant for recombinant MVA vector for generating immune response to hemorrhagic viruseson April 17, 2024 at 5:35 am
Discover how GeoVax Labs Inc's patented MVA vector technology targets deadly hemorrhagic fever viruses like ebolavirus and Marburgvirus, offering both preventive and therapeutic benefits.
- Vaccines targeting chronic diseases show promise in combatting age-related conditionson April 17, 2024 at 3:32 am
Vaccines for age-related vascular diseases such as hypertension, abdominal aortic aneurysm (AAA), and atherosclerosis target molecules that regulate blood pressure, cholesterol, and blood vessel ...
- Nvelop launches to deliver gene-editing cargoon April 11, 2024 at 1:25 pm
Nvelop Therapeutics has launched to improve gene therapy delivery. The company was first founded in 2022 with $100 million in funding from investors on the basis of independently developed platforms ...
The Latest Google Headlines on:
Virus-derived particles
[google_news title=”” keyword=”Virus-derived particles” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Non-replicating virus-derived particle
- Feed has no items.
The Latest Google Headlines on:
Non-replicating virus-derived particle
[google_news title=”” keyword=”non-replicating virus-derived particle” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]